vs

Side-by-side financial comparison of United Rentals (URI) and Vertex Pharmaceuticals (VRTX). Click either name above to swap in a different company.

United Rentals is the larger business by last-quarter revenue ($4.0B vs $3.2B, roughly 1.2× Vertex Pharmaceuticals). Vertex Pharmaceuticals runs the higher net margin — 37.3% vs 13.3%, a 24.0% gap on every dollar of revenue. On growth, Vertex Pharmaceuticals posted the faster year-over-year revenue change (9.5% vs 7.2%). United Rentals produced more free cash flow last quarter ($1.1B vs $348.6M). Over the past eight quarters, United Rentals's revenue compounded faster (114.0% CAGR vs 8.9%).

United Rentals, Inc. is an American equipment rental company, with about 16 percent of the North American market share as of 2022. It owns the largest rental fleet in the world with approximately 4,800 classes of equipment totaling about $20.59 billion in original equipment cost (OEC) as of 2025. The company has a combined total of 1,625 locations, including an integrated network of 1,504 rental locations in North America, 38 in Europe, 23 in Australia and 19 in New Zealand.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

URI vs VRTX — Head-to-Head

Bigger by revenue
URI
URI
1.2× larger
URI
$4.0B
$3.2B
VRTX
Growing faster (revenue YoY)
VRTX
VRTX
+2.4% gap
VRTX
9.5%
7.2%
URI
Higher net margin
VRTX
VRTX
24.0% more per $
VRTX
37.3%
13.3%
URI
More free cash flow
URI
URI
$705.4M more FCF
URI
$1.1B
$348.6M
VRTX
Faster 2-yr revenue CAGR
URI
URI
Annualised
URI
114.0%
8.9%
VRTX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
URI
URI
VRTX
VRTX
Revenue
$4.0B
$3.2B
Net Profit
$531.0M
$1.2B
Gross Margin
36.9%
85.4%
Operating Margin
21.8%
37.8%
Net Margin
13.3%
37.3%
Revenue YoY
7.2%
9.5%
Net Profit YoY
30.5%
EPS (diluted)
$8.43
$4.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
URI
URI
VRTX
VRTX
Q1 26
$4.0B
Q4 25
$992.0M
$3.2B
Q3 25
$938.0M
$3.1B
Q2 25
$872.0M
$3.0B
Q1 25
$893.0M
$2.8B
Q4 24
$1.0B
$2.9B
Q3 24
$874.0M
$2.8B
Q2 24
$870.0M
$2.6B
Net Profit
URI
URI
VRTX
VRTX
Q1 26
$531.0M
Q4 25
$653.0M
$1.2B
Q3 25
$701.0M
$1.1B
Q2 25
$622.0M
$1.0B
Q1 25
$518.0M
$646.3M
Q4 24
$689.0M
$913.0M
Q3 24
$708.0M
$1.0B
Q2 24
$636.0M
$-3.6B
Gross Margin
URI
URI
VRTX
VRTX
Q1 26
36.9%
Q4 25
85.4%
Q3 25
86.5%
Q2 25
86.3%
Q1 25
86.9%
Q4 24
85.5%
Q3 24
85.8%
Q2 24
85.9%
Operating Margin
URI
URI
VRTX
VRTX
Q1 26
21.8%
Q4 25
37.8%
Q3 25
38.6%
Q2 25
38.8%
Q1 25
90.0%
22.7%
Q4 24
35.2%
Q3 24
40.3%
Q2 24
-132.9%
Net Margin
URI
URI
VRTX
VRTX
Q1 26
13.3%
Q4 25
65.8%
37.3%
Q3 25
74.7%
35.2%
Q2 25
71.3%
34.8%
Q1 25
58.0%
23.3%
Q4 24
67.6%
31.4%
Q3 24
81.0%
37.7%
Q2 24
73.1%
-135.8%
EPS (diluted)
URI
URI
VRTX
VRTX
Q1 26
$8.43
Q4 25
$10.20
$4.64
Q3 25
$10.91
$4.20
Q2 25
$9.59
$3.99
Q1 25
$7.91
$2.49
Q4 24
$10.41
$3.62
Q3 24
$10.70
$4.01
Q2 24
$9.54
$-13.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
URI
URI
VRTX
VRTX
Cash + ST InvestmentsLiquidity on hand
$156.0M
$6.6B
Total DebtLower is stronger
$13.9B
Stockholders' EquityBook value
$9.0B
$18.7B
Total Assets
$29.9B
$25.6B
Debt / EquityLower = less leverage
1.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
URI
URI
VRTX
VRTX
Q1 26
$156.0M
Q4 25
$459.0M
$6.6B
Q3 25
$512.0M
$6.3B
Q2 25
$548.0M
$6.4B
Q1 25
$542.0M
$6.2B
Q4 24
$457.0M
$6.1B
Q3 24
$479.0M
$6.5B
Q2 24
$467.0M
$5.8B
Total Debt
URI
URI
VRTX
VRTX
Q1 26
$13.9B
Q4 25
$12.7B
Q3 25
$12.6B
Q2 25
$12.1B
Q1 25
$11.5B
Q4 24
$12.2B
Q3 24
$11.9B
Q2 24
$11.5B
Stockholders' Equity
URI
URI
VRTX
VRTX
Q1 26
$9.0B
Q4 25
$9.0B
$18.7B
Q3 25
$9.0B
$17.3B
Q2 25
$9.0B
$17.2B
Q1 25
$8.8B
$16.5B
Q4 24
$8.6B
$16.4B
Q3 24
$8.6B
$15.6B
Q2 24
$8.3B
$14.8B
Total Assets
URI
URI
VRTX
VRTX
Q1 26
$29.9B
Q4 25
$29.9B
$25.6B
Q3 25
$30.1B
$24.9B
Q2 25
$29.2B
$24.0B
Q1 25
$28.1B
$22.9B
Q4 24
$28.2B
$22.5B
Q3 24
$28.4B
$22.2B
Q2 24
$27.6B
$20.1B
Debt / Equity
URI
URI
VRTX
VRTX
Q1 26
1.55×
Q4 25
1.41×
Q3 25
1.40×
Q2 25
1.34×
Q1 25
1.31×
Q4 24
1.42×
Q3 24
1.38×
Q2 24
1.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
URI
URI
VRTX
VRTX
Operating Cash FlowLast quarter
$1.5B
$498.0M
Free Cash FlowOCF − Capex
$1.1B
$348.6M
FCF MarginFCF / Revenue
26.4%
10.9%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
2.85×
0.42×
TTM Free Cash FlowTrailing 4 quarters
$3.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
URI
URI
VRTX
VRTX
Q1 26
$1.5B
Q4 25
$1.3B
$498.0M
Q3 25
$1.2B
$1.2B
Q2 25
$1.3B
$1.1B
Q1 25
$1.4B
$818.9M
Q4 24
$1.0B
$584.6M
Q3 24
$1.2B
$1.4B
Q2 24
$1.3B
$-3.8B
Free Cash Flow
URI
URI
VRTX
VRTX
Q1 26
$1.1B
Q4 25
$348.6M
Q3 25
$1.1B
Q2 25
$927.4M
Q1 25
$778.2M
Q4 24
$471.0M
$492.0M
Q3 24
$-168.0M
$1.3B
Q2 24
$-263.0M
$-3.8B
FCF Margin
URI
URI
VRTX
VRTX
Q1 26
26.4%
Q4 25
10.9%
Q3 25
37.0%
Q2 25
31.3%
Q1 25
28.1%
Q4 24
46.2%
16.9%
Q3 24
-19.2%
47.0%
Q2 24
-30.2%
-144.5%
Capex Intensity
URI
URI
VRTX
VRTX
Q1 26
Q4 25
4.7%
Q3 25
3.3%
Q2 25
4.9%
Q1 25
1.5%
Q4 24
56.6%
3.2%
Q3 24
157.0%
2.4%
Q2 24
175.6%
2.6%
Cash Conversion
URI
URI
VRTX
VRTX
Q1 26
2.85×
Q4 25
1.92×
0.42×
Q3 25
1.68×
1.15×
Q2 25
2.14×
1.04×
Q1 25
2.75×
1.27×
Q4 24
1.52×
0.64×
Q3 24
1.70×
1.31×
Q2 24
1.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

URI
URI

Equipment rentals$3.4B86%
Sales of rental equipment$350.0M9%
Service and other revenues$92.0M2%
Sales of new equipment$84.0M2%
Contractor supplies sales$40.0M1%

VRTX
VRTX

TRIKAFTAKAFTRIO$2.6B81%
ALYFTREK$380.1M12%
Manufactured Product Other$237.4M7%

Related Comparisons